Indian-made Covovax listed for emergency use to increase access to vaccination in lower-income countries

KATHMANDU, December 19: With aim to increase access to vaccination in lower-income countries, the World Health Organization has recently listed Indian-made Covovax (NVX-CoV2373) for emergency use.

According to a press statement of the WHO, the vaccine, named Covovax, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio, giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries.